MWNA
APTX

Marshall Wace North America’s Aptinyx Inc. Common Stock APTX Stock Holding History

Marshall Wace North America’s Portfolio APTX Stock Details APTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q1 		– Sell
-16,986
Closed -$58K – 1698
2019
Q4 		$58K Hold
16,986
– – ﹤0.01% 1139
2019
Q3 		$59K Buy
+16,986
New +$61K ﹤0.01% 1141
2018
Q3 		– Sell
-45,556
Closed -$1.1M – 1480
2018
Q2 		$1.1M Buy
+45,556
New +$975K 0.01% 904

Other funds holding APTX

BCLSI
Bain Capital Life Sciences Investors Boston, Massachusetts $1.11B AUM 171.34% 1-Year Est. Return
ASP
Adams Street Partners Chicago, Illinois $260M AUM 30.38% 1-Year Est. Return
NLVP
New Leaf Venture Partners New York $43M AUM 25.55% 1-Year Est. Return
FM
Frazier Management Seattle, Washington $1.12M AUM 151.58% 1-Year Est. Return
AG
Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
IC
Ikarian Capital Dallas, Texas $1.23B AUM 600.17% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Marshall Wace North America's APTX Position: Q1 2020 in Review

Marshall Wace North America sold out of Aptinyx Inc. Common Stock (APTX) in Q1 2020, closing a stake of 16,986 shares — an estimated $58K sold.

Marshall Wace North America first reported a position in APTX in Q2 2018 and held it in 3 quarters. The position peaked at $1.1M in Q2 2018. 59 funds tracked by Wall St. Rank hold APTX as of Q1 2020.

  • Marshall Wace North America reported no remaining Aptinyx Inc. Common Stock position as of Q1 2020 after selling out during the quarter.
  • Marshall Wace North America sold 16,986 Aptinyx Inc. Common Stock shares in Q1 2020, an estimated $58K.
  • Marshall Wace North America first reported a position in Aptinyx Inc. Common Stock in Q2 2018 and held it in 3 quarters.
  • Marshall Wace North America's Aptinyx Inc. Common Stock position peaked at $1.1M in Q2 2018.
  • 59 funds tracked by Wall St. Rank held Aptinyx Inc. Common Stock as of Q1 2020.

Based on Marshall Wace North America's 13F filing for Q1 2020, filed 15 May 2020.